2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β

Cancer Research

Volumn 62, Issue 13, 2002, Pages 3691-3697

  LaVallee, Theresa M ^a   Zhan, Xiaoguo H ^a   Herbstritt, Chris J ^a   Kough, Emily C ^a   Green, Shawn J ^a   Pribluda, Victor S ^a  

^a ENTREMED INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; CYTOCHROME P450; DNA; ENZYME INHIBITOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GALANGIN; RECOMBINANT ENZYME; TAMOXIFEN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR GROWTH;

APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVONOIDS; HUMANS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0036645421     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. 2-Methoxyestradiol: An endogenous antiangiogenic and antiproliferative drug candidate
2. Biogenesis and metabolism of catechol estrogens in vitro
3. Angiostatic treatment of neumblastoma
4. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
5. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors
6. Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts
7. Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer
8. 2-Methoxyestradiol: An orally active agent in a broad range of primary and metastatic tumor models
9. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol
10. Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol
11. Carcinogenicity of catechol estrogens in Syrian hamsters
12. Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion
13. Effects of catechol estrogen methyl ethers on lipid metabolism in prepubertal rats
14. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol
15. Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers
16. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site
17. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: Uncoupling from JNK/SAPK activation
18. The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells
19. 2-Methoxyestradiol upregulates DR5 and induces apoptosis independently of p53 in endothelial cells and tumor cells
20. Superoxide dismutase as a target for the selective killing of cancer cells
21. ER β: Identification and characterization of a novel human estrogen receptor
22. Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth
23. Hormone- and DNA-binding mechanisms of the recombinant human estrogen receptor
24. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction
25. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
26. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
27. Use of the monoclonal antibody DAKO-ERβ (8D5-1) to measure estrogen receptor β in breast cancer cells
28. Metabolic fate of catechol estrogens
29. P450 enzymes of estrogen metabolism
30. Functional role of estrogen metabolism in target cells: Review and perspectives
31. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study
32. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines
33. Growth inhibitory effects of flavonoids in human thyroid cancer cell lines
34. The cytotoxic effects of estradiol-17 β. Catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells
35. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
36. Effects of 17 β-estradiol metabolites on cell cycle events in MCF-7 cells
37. The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells
38. 17β-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth
39. Anti-proliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta
40. Catecholestrogens inhibit proliferation and DNA synthesis of porcine granulosa cells in vitro: Comparison with estradiol, 5 α-dihydrotestosterone, gonadotropins and catecholamines
41. 17β-estradiol metabolites affect some regulators of the MCF-7 cell cycle
42. Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells
43. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells
44. Preclinical development of 2-methoxyestradiol (2ME2.NSC-659853)
45. An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats
46. 2-Methoxyestradiol inhibits longitudinal bone growth in normal female rats
47. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism
48. Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis
49. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
50. Molecular mechanisms of estrogen action: Selective ligands and receptor pharmacology
51. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR β